A higher pulmonary vascular resistance index during exercise, but not at rest, predicts poor clinical outcomes in adults with ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback